Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots

Fujio Suzuki, D. A. Schmitt, T. Utsunomiya, R. B. Pollard

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The effect of glycyrrhizin (GR), a Chinese herbal drug extracted from licorice roots, on the host resistance to tumors was investigated in a murine system. Administration of GR to BALB/c mice, which were inoculated s.c. with 1 x 106 cells/mouse of Meth A tumors, resulted in either no antitumor effect (8/20, 40%), a delay in tumor growth (9/20, 45%), or elimination of tumor growth (3/20, 15%) in these mice. In addition, the incidence of Meth A solid tumors was inhibited by GR when mice were inoculated with 1.5 x 104 cells/mouse or less of Meth A tumor cells, but not 7.5 x 104 cells/mouse or more. These results indicate that in this murine tumor system GR has a very weak antitumor effect. When GR at a dose of 20 mg/kg was administered to mice immunized with allogeneic lymphocytes 1 to 9 days after the immunization, the generation of suppressor macrophages (S-M∅) was clearly reduced as compared with that of S-M∅ generated in immunized controls. In addition, when allospecific CTL (allo-CTL), which were generated in alloimmunized mice treated with GR followed by in vitro stimulation with allogeneic lymphocytes in a mixed lymphocyte reaction, were adoptively transferred to tumor-bearing mice treated with GR, the antitumor activity of allo-CTL derived from immunized mice treated with GR was markedly enhanced as compared with that of allo-CTL from immunized mice. Furthermore, established solid tumors were completely eliminated when interleukin-2 immunotherapy was performed in these mice in combination with GR treatments, but not interleukin-2 or GR alone. These results suggest that, even though GR has a very weak antitumor activity, the CTL or IL-2 immunotherapy against tumors will be more successful when combined with the compound, because GR acts as an inhibitor of S-M∅.

Original languageEnglish (US)
Pages (from-to)589-596
Number of pages8
JournalIn Vivo
Volume6
Issue number6
StatePublished - 1992

Fingerprint

Glycyrrhizic Acid
Glycyrrhiza
Tumors
Neoplasms
Lymphocytes
Interleukin-2
Macrophages
Immunotherapy
Chinese Herbal Drugs
Bearings (structural)
Immunization
Mixed Lymphocyte Culture Test
Growth

Keywords

  • allospecific cytotoxic T lymphocytes
  • glycyrrhizin
  • immunotherapy
  • suppressor macrophages

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Suzuki, F., Schmitt, D. A., Utsunomiya, T., & Pollard, R. B. (1992). Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. In Vivo, 6(6), 589-596.

Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. / Suzuki, Fujio; Schmitt, D. A.; Utsunomiya, T.; Pollard, R. B.

In: In Vivo, Vol. 6, No. 6, 1992, p. 589-596.

Research output: Contribution to journalArticle

Suzuki, F, Schmitt, DA, Utsunomiya, T & Pollard, RB 1992, 'Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots', In Vivo, vol. 6, no. 6, pp. 589-596.
Suzuki, Fujio ; Schmitt, D. A. ; Utsunomiya, T. ; Pollard, R. B. / Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. In: In Vivo. 1992 ; Vol. 6, No. 6. pp. 589-596.
@article{af8d35c23a35478db4999be0820b5614,
title = "Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots",
abstract = "The effect of glycyrrhizin (GR), a Chinese herbal drug extracted from licorice roots, on the host resistance to tumors was investigated in a murine system. Administration of GR to BALB/c mice, which were inoculated s.c. with 1 x 106 cells/mouse of Meth A tumors, resulted in either no antitumor effect (8/20, 40{\%}), a delay in tumor growth (9/20, 45{\%}), or elimination of tumor growth (3/20, 15{\%}) in these mice. In addition, the incidence of Meth A solid tumors was inhibited by GR when mice were inoculated with 1.5 x 104 cells/mouse or less of Meth A tumor cells, but not 7.5 x 104 cells/mouse or more. These results indicate that in this murine tumor system GR has a very weak antitumor effect. When GR at a dose of 20 mg/kg was administered to mice immunized with allogeneic lymphocytes 1 to 9 days after the immunization, the generation of suppressor macrophages (S-M∅) was clearly reduced as compared with that of S-M∅ generated in immunized controls. In addition, when allospecific CTL (allo-CTL), which were generated in alloimmunized mice treated with GR followed by in vitro stimulation with allogeneic lymphocytes in a mixed lymphocyte reaction, were adoptively transferred to tumor-bearing mice treated with GR, the antitumor activity of allo-CTL derived from immunized mice treated with GR was markedly enhanced as compared with that of allo-CTL from immunized mice. Furthermore, established solid tumors were completely eliminated when interleukin-2 immunotherapy was performed in these mice in combination with GR treatments, but not interleukin-2 or GR alone. These results suggest that, even though GR has a very weak antitumor activity, the CTL or IL-2 immunotherapy against tumors will be more successful when combined with the compound, because GR acts as an inhibitor of S-M∅.",
keywords = "allospecific cytotoxic T lymphocytes, glycyrrhizin, immunotherapy, suppressor macrophages",
author = "Fujio Suzuki and Schmitt, {D. A.} and T. Utsunomiya and Pollard, {R. B.}",
year = "1992",
language = "English (US)",
volume = "6",
pages = "589--596",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots

AU - Suzuki, Fujio

AU - Schmitt, D. A.

AU - Utsunomiya, T.

AU - Pollard, R. B.

PY - 1992

Y1 - 1992

N2 - The effect of glycyrrhizin (GR), a Chinese herbal drug extracted from licorice roots, on the host resistance to tumors was investigated in a murine system. Administration of GR to BALB/c mice, which were inoculated s.c. with 1 x 106 cells/mouse of Meth A tumors, resulted in either no antitumor effect (8/20, 40%), a delay in tumor growth (9/20, 45%), or elimination of tumor growth (3/20, 15%) in these mice. In addition, the incidence of Meth A solid tumors was inhibited by GR when mice were inoculated with 1.5 x 104 cells/mouse or less of Meth A tumor cells, but not 7.5 x 104 cells/mouse or more. These results indicate that in this murine tumor system GR has a very weak antitumor effect. When GR at a dose of 20 mg/kg was administered to mice immunized with allogeneic lymphocytes 1 to 9 days after the immunization, the generation of suppressor macrophages (S-M∅) was clearly reduced as compared with that of S-M∅ generated in immunized controls. In addition, when allospecific CTL (allo-CTL), which were generated in alloimmunized mice treated with GR followed by in vitro stimulation with allogeneic lymphocytes in a mixed lymphocyte reaction, were adoptively transferred to tumor-bearing mice treated with GR, the antitumor activity of allo-CTL derived from immunized mice treated with GR was markedly enhanced as compared with that of allo-CTL from immunized mice. Furthermore, established solid tumors were completely eliminated when interleukin-2 immunotherapy was performed in these mice in combination with GR treatments, but not interleukin-2 or GR alone. These results suggest that, even though GR has a very weak antitumor activity, the CTL or IL-2 immunotherapy against tumors will be more successful when combined with the compound, because GR acts as an inhibitor of S-M∅.

AB - The effect of glycyrrhizin (GR), a Chinese herbal drug extracted from licorice roots, on the host resistance to tumors was investigated in a murine system. Administration of GR to BALB/c mice, which were inoculated s.c. with 1 x 106 cells/mouse of Meth A tumors, resulted in either no antitumor effect (8/20, 40%), a delay in tumor growth (9/20, 45%), or elimination of tumor growth (3/20, 15%) in these mice. In addition, the incidence of Meth A solid tumors was inhibited by GR when mice were inoculated with 1.5 x 104 cells/mouse or less of Meth A tumor cells, but not 7.5 x 104 cells/mouse or more. These results indicate that in this murine tumor system GR has a very weak antitumor effect. When GR at a dose of 20 mg/kg was administered to mice immunized with allogeneic lymphocytes 1 to 9 days after the immunization, the generation of suppressor macrophages (S-M∅) was clearly reduced as compared with that of S-M∅ generated in immunized controls. In addition, when allospecific CTL (allo-CTL), which were generated in alloimmunized mice treated with GR followed by in vitro stimulation with allogeneic lymphocytes in a mixed lymphocyte reaction, were adoptively transferred to tumor-bearing mice treated with GR, the antitumor activity of allo-CTL derived from immunized mice treated with GR was markedly enhanced as compared with that of allo-CTL from immunized mice. Furthermore, established solid tumors were completely eliminated when interleukin-2 immunotherapy was performed in these mice in combination with GR treatments, but not interleukin-2 or GR alone. These results suggest that, even though GR has a very weak antitumor activity, the CTL or IL-2 immunotherapy against tumors will be more successful when combined with the compound, because GR acts as an inhibitor of S-M∅.

KW - allospecific cytotoxic T lymphocytes

KW - glycyrrhizin

KW - immunotherapy

KW - suppressor macrophages

UR - http://www.scopus.com/inward/record.url?scp=0027080624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027080624&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 589

EP - 596

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 6

ER -